Evidence mapPaperPMID 37137499Full record

ReviewCold Spring Harbor perspectives in medicine2023

Discovering Biological Mechanisms of Exceptional Human Health Span and Life Span.

Sofiya Milman, Nir Barzilai

Open access · bronzeAbstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Super Movers: Epidemiology and Biology of a Novel Exceptional Aging Phenotype.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Article
  4. Article
  5. Suppressing APOE4-induced neural pathologies by targeting the VHL-HIF axis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Article
  8. Geroscience and Its Promise.Cold Spring Harbor perspectives in medicine · 2024
    Review
  9. Suppressing APOE4-induced mortality and cellular damage by targeting VHL.bioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sofiya MilmanInstitute for Aging Research, Department of Medicine, Divisions of Endocrinology and Geriatrics, Department of Genetics, Albert Einstein College of Medicine, Bronx, New York 10461, USA Sofiya.milman@einsteinmed.edu.
Nir BarzilaiInstitute for Aging Research, Department of Medicine, Divisions of Endocrinology and Geriatrics, Department of Genetics, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Albert Einstein College of Medicine · US

Funding

Excess nutrients and the metabolic syndrome of agingP01AG021654 · YESHIVA UNIVERSITY · 2003 to 2005
$6.3M
Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategiesUH3AG064704 · BOSTON UNIVERSITY MEDICAL CAMPUS · 2025 to 2025
$4.8M
Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO)U19AG073172 · BOSTON UNIVERSITY MEDICAL CAMPUS · 2025 to 2025
$4.6M
NIA NIH HHS P01 AG021654NIA NIH HHS P30 AG038072NIA NIH HHS R01 AG061155NIA NIH HHS R56 AG044829NIA NIH HHS U19 AG073172NIA NIH HHS UH3 AG064704
6 · The paper itself

Abstract

Humans age at different rates and families with exceptional longevity provide an opportunity to understand why some people age slower than others. Unique features exhibited by centenarians include a family history of extended life span, compression of morbidity with resultant extension of health span, and longevity-associated biomarker profiles. These biomarkers, including low-circulating insulin-like growth factor 1 (IGF-1) and elevated high-density lipoprotein (HDL) cholesterol levels, are associated with functional genotypes that are enriched in centenarians, suggesting that they may be causative for longevity. While not all genetic discoveries from centenarians have been validated, in part due to exceptional life span being a rare phenotype in the general population, the APOE2 and FOXO3a genotypes have been confirmed in a number of populations with exceptional longevity. However, life span is now recognized as a complex trait and genetic research methods to study longevity are rapidly extending beyond classical Mendelian genetics to polygenic inheritance methodologies. Moreover, newer approaches are suggesting that pathways that have been recognized for decades to control life span in animals may also regulate life span in humans. These discoveries led to strategic development of therapeutics that may delay aging and prolong health span.

Indexed as

AgingLongevityAged, 80 and overAnimalsBiomarkersGenotypeHumansPhenotypeBiomarkers

Identifiers

PMID37137499
PMCPMC10513160
OpenAlexW4367842608

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.